Skip to main content
NVDA-0.29%AAPL+1.03%GOOGL-2.28%MSFT-0.01%AMZN-0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.70%TSLA-0.62%SKHY+7.05%MU-1.56%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.62%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.84%0005.HK-0.78%HSBA.L-1.78%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.28%CHFJPY-1.76%USDJPY-1.63%AUDJPY-1.56%EURJPY-1.45%CADJPY-1.45%GBPJPY-1.41%GBPNZD+0.87%EURNZD+0.86%NZDCAD-0.85%AUDNZD+0.75%NZDUSD-0.68%NZDCHF-0.55%GBPTRY+0.41%GBPCHF+0.34%GBPHKD+0.32%EURCHF+0.31%CADCHF+0.30%GBPMXN-0.28%EURZAR+0.26%EURNOK+0.25%USDNOK+0.25%USDZAR+0.24%GBPZAR+0.22%GBPUSD+0.21%AUDCHF+0.21%EURUSD+0.17%USDCAD-0.16%USDILS+0.16%CHFNOK+0.16%USDCHF+0.15%NOKJPY-0.14%NZDSGD+0.14%AUDDKK-0.14%AUDCAD-0.13%GBPAUD+0.12%USDTHB+0.12%AUDNOK+0.11%EURAUD+0.11%USDTRY+0.11%EURSEK+0.10%USDSEK+0.09%EURSGD+0.09%USDSGD+0.09%NZDMXN+0.07%EURCZK-0.07%EURPLN+0.07%AUDUSD+0.07%USDPLN+0.06%GBPSGD+0.06%AUDSGD-0.05%USDMXN+0.04%PLNJPY+0.04%USDCOP-0.04%USDCNH-0.03%SGDJPY+0.02%GBPCAD+0.02%EURGBP-0.02%USDHKD+0.01%CHFSGD-0.01%EURHKD0.00%EURDKK0.00%EURCNH0.00%EURCAD0.00%CHFSEK0.00%USDDKK0.00%COFFEE-2.29%XPTUSD-1.82%SUGAR+1.74%COCOA-1.52%COTTON+1.30%XAGUSD-1.16%GAGUSD-1.16%USOIL+0.81%UKOIL+0.69%HG1-0.58%S1+0.56%C1+0.52%BTCUSD-0.46%ETHUSD-0.08%USDTUSD-0.07%XRPUSD-1.36%SOLUSD-0.68%TRXUSDT+0.39%ZECUSDT-2.20%DOGEUSD-1.46%XMRUSDT-1.03%LINKUSD-0.27%XLMUSD-1.16%BCHUSDT-1.97%LTCUSD-1.80%UNIUSD-2.83%TONUSD+24.88%HBARUSDT-1.34%SUIUSD-1.61%TAOUSDT-1.18%AAVEUSD-1.60%DOTUSDT-2.54%ICPUSDT-1.21%ONDOUSDT-2.17%WLDUSDT-2.19%ATOMUSDT-2.27%ARBUSDT-1.00%JUPUSDT-2.96%INJUSDT-2.53%STXUSDT-3.07%FETUSDT-2.45%TIAUSDT-1.13%SEIUSDT-3.91%PYTHUSDT-1.40%IMXUSDT-2.27%WIFUSDT-3.42%GRTUSDT-2.41%OPUSDT-3.00%POLUSDT-2.75%IOTAUSDT-2.57%AXSUSDT-2.14%FARTCOINUSDT-1.81%EOSUSDT-0.31%DYDXUSDT-0.60%ORDIUSDT+0.34%GALAUSDT-3.65%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.29%AAPL+1.03%GOOGL-2.28%MSFT-0.01%AMZN-0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.70%TSLA-0.62%SKHY+7.05%MU-1.56%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.62%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.84%0005.HK-0.78%HSBA.L-1.78%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.28%CHFJPY-1.76%USDJPY-1.63%AUDJPY-1.56%EURJPY-1.45%CADJPY-1.45%GBPJPY-1.41%GBPNZD+0.87%EURNZD+0.86%NZDCAD-0.85%AUDNZD+0.75%NZDUSD-0.68%NZDCHF-0.55%GBPTRY+0.41%GBPCHF+0.34%GBPHKD+0.32%EURCHF+0.31%CADCHF+0.30%GBPMXN-0.28%EURZAR+0.26%EURNOK+0.25%USDNOK+0.25%USDZAR+0.24%GBPZAR+0.22%GBPUSD+0.21%AUDCHF+0.21%EURUSD+0.17%USDCAD-0.16%USDILS+0.16%CHFNOK+0.16%USDCHF+0.15%NOKJPY-0.14%NZDSGD+0.14%AUDDKK-0.14%AUDCAD-0.13%GBPAUD+0.12%USDTHB+0.12%AUDNOK+0.11%EURAUD+0.11%USDTRY+0.11%EURSEK+0.10%USDSEK+0.09%EURSGD+0.09%USDSGD+0.09%NZDMXN+0.07%EURCZK-0.07%EURPLN+0.07%AUDUSD+0.07%USDPLN+0.06%GBPSGD+0.06%AUDSGD-0.05%USDMXN+0.04%PLNJPY+0.04%USDCOP-0.04%USDCNH-0.03%SGDJPY+0.02%GBPCAD+0.02%EURGBP-0.02%USDHKD+0.01%CHFSGD-0.01%EURHKD0.00%EURDKK0.00%EURCNH0.00%EURCAD0.00%CHFSEK0.00%USDDKK0.00%COFFEE-2.29%XPTUSD-1.82%SUGAR+1.74%COCOA-1.52%COTTON+1.30%XAGUSD-1.16%GAGUSD-1.16%USOIL+0.81%UKOIL+0.69%HG1-0.58%S1+0.56%C1+0.52%BTCUSD-0.46%ETHUSD-0.08%USDTUSD-0.07%XRPUSD-1.36%SOLUSD-0.68%TRXUSDT+0.39%ZECUSDT-2.20%DOGEUSD-1.46%XMRUSDT-1.03%LINKUSD-0.27%XLMUSD-1.16%BCHUSDT-1.97%LTCUSD-1.80%UNIUSD-2.83%TONUSD+24.88%HBARUSDT-1.34%SUIUSD-1.61%TAOUSDT-1.18%AAVEUSD-1.60%DOTUSDT-2.54%ICPUSDT-1.21%ONDOUSDT-2.17%WLDUSDT-2.19%ATOMUSDT-2.27%ARBUSDT-1.00%JUPUSDT-2.96%INJUSDT-2.53%STXUSDT-3.07%FETUSDT-2.45%TIAUSDT-1.13%SEIUSDT-3.91%PYTHUSDT-1.40%IMXUSDT-2.27%WIFUSDT-3.42%GRTUSDT-2.41%OPUSDT-3.00%POLUSDT-2.75%IOTAUSDT-2.57%AXSUSDT-2.14%FARTCOINUSDT-1.81%EOSUSDT-0.31%DYDXUSDT-0.60%ORDIUSDT+0.34%GALAUSDT-3.65%NOTUSDT-0.68%RONINUSDT-0.71%
MG

Myriad Genetics, Inc. (MYGN)

NASDAQ • Healthcare

$3.19
+$0 (+0.3%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$3.11
Day Range$3.09 - $3.22
Avg. Volume (3M)1.5M
Market Cap$301.2M
52 Week Range
$2.74$8.59
Next EarningsIn 53 daysNov 2, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$190.7M100%
Gross Profitminus cost of goods$127M67%

In plain terms: out of every $100 in revenue, Myriad Genetics, Inc. currently loses $23.

Fundamentals & Financials

Revenue (TTM)
$806.6M
Net Income (TTM)
-$112.6M
EPS (TTM)
-$1.19
ROA (TTM)
-17.62%
Current Ratio
2.21
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+300.0%Q1 2026$0.04
-50.0%Q2 2026-$0.09
-331.9%Q3 2026-$0.25
Next

Nov 2

in 53 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Myriad Genetics, Inc.

Myriad Genetics, Inc. (NASDAQ: MYGN) develops and sells molecular diagnostic tests in healthcare, focused on medical diagnostics and research across oncology, women's health, and pharmacogenomics. In FY2025, Myriad generated $824.5 million of revenue. Its menu spans hereditary cancer, tumor profiling, prenatal screening, carrier screening, and medication-selection testing.

Name
Myriad Genetics, Inc.
CEO
Samraat S. Raha
Website
www.myriad.com
Industry
Healthcare
Year Founded
1991
Employees
2,700

Today's Snapshot

AI-generated

The day ended with MYGN slightly higher at 3.19, in line with a flat sector. Shares changed hands at about two-thirds of its usual level. Myriad Genetics enhanced its Prolaris prostate cancer test with AI for deeper analysis.

Trading Volume

Below 10d avg (1.4M)

966.9K

vs S&P 500 Today

Outperforming Market

+0.73%

Updated: September 9, 2026 at 20:27 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
MYGN, trading near $3.19, shows a strong sell profile underpinned by a well-established downtrend and persistent negative volume. ADX points to a strong directional trend lower, multiple mid- and long-term moving averages lie above the current price, and ATR as a percentage is elevated, reflecting relatively high price swings. Momentum and MACD are muted, oscillators sit around neutral or mildly weak levels, and OBV is deeply negative, underscoring distribution. Technical takeaway: Strong Sell — strong downward trend with weak momentum and confirming negative volume.
All signals
  • EMA (5 indicators)$3.19 - $5.17
    Sell
  • RSI (14)39.09
    Neutral
  • Stochastic %K (14, 3, 3)63.96
    Neutral
  • MACD Level (12, 26)-0.24
    Neutral

Peers & Related Assets

CDNACareDx, Inc
$50.03-0.6%
MRVIMaravai LifeSciences Holdings, Inc.
$6.95-3.3%
VIRVir Biotechnology, Inc.
$10.81-3.3%
AMNAMN Healthcare Services, Inc.
$34.36+1.9%
CSTLCastle Biosciences, Inc.
$32.31-1.4%
FLGTFulgent Genetics, Inc.
$19.85-1.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.